Skip to main navigation Skip to search Skip to main content

Homozygous and Heterozygous PINK1 mutations: Considerations for diagnosis and care of Parkinson's disease patients

Cindy Zadikoff, Ekaterina Rogaeva, Ana Djarmati, Christine Sato, Shabnam Salehi-Rad, Peter St. George-Hyslop, Christine Klein, Anthony E. Lang*

*Corresponding author for this work

Abstract

The first mutations described in PINK1 were homozygous. More recently, heterozygous mutations have been reported but the role of heterozygosity in disease pathogenesis is still debated. We describe two unrelated cases with PINK1 mutations (homozygous nonsense and heterozygous missense) that highlight issues regarding the role of heterozygous mutations and the utility of genetic screening in patient care.

Original languageEnglish
JournalMovement Disorders
Volume21
Issue number6
Pages (from-to)875-879
Number of pages5
ISSN0885-3185
DOIs
Publication statusPublished - 01.06.2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Homozygous and Heterozygous PINK1 mutations: Considerations for diagnosis and care of Parkinson's disease patients'. Together they form a unique fingerprint.

Cite this